Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 666

1.

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.

Savelieva I, Camm J.

Europace. 2008 Jun;10(6):647-65. doi: 10.1093/europace/eun130. Review.

PMID:
18515286
2.

Novel approaches for pharmacological management of atrial fibrillation.

Ehrlich JR, Nattel S.

Drugs. 2009;69(7):757-74. doi: 10.2165/00003495-200969070-00001. Review.

PMID:
19441867
3.

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.

Singh BN.

J Cardiovasc Electrophysiol. 1999 Feb;10(2):283-301. Review.

PMID:
10090235
4.

Pharmacological approaches in the treatment of atrial fibrillation.

Tamargo J, Caballero R, Delpón E.

Curr Med Chem. 2004 Jan;11(1):13-28. Review.

PMID:
14754423
5.

Novel anti-arrhythmic drugs for atrial fibrillation management.

Ehrlich JR, Nattel S, Hohnloser SH.

Curr Vasc Pharmacol. 2007 Jul;5(3):185-95. Review.

PMID:
17627562
6.

Do we need pharmacological therapy for atrial fibrillation in the ablation era?

Lévy S.

J Interv Card Electrophysiol. 2006 Dec;17(3):189-94. Epub 2007 Mar 6. Review.

PMID:
17340189
7.

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

Savelieva I, Kakouros N, Kourliouros A, Camm AJ.

Europace. 2011 Mar;13(3):308-28. doi: 10.1093/europace/eur002. Review.

PMID:
21345926
8.

Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.

Li D, Sun H, Levesque P.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):64-75. Review.

PMID:
19149545
9.

New antiarrhythmic drugs for prevention of atrial fibrillation.

Goldstein RN, Stambler BS.

Prog Cardiovasc Dis. 2005 Nov-Dec;48(3):193-208. Review.

PMID:
16271945
10.

Vernakalant: RSD 1235, RSD-1235, RSD1235.

[No authors listed]

Drugs R D. 2007;8(4):259-65. Review.

PMID:
17596113
11.

Pharmacologic management of atrial fibrillation: current therapeutic strategies.

Lévy S.

Am Heart J. 2001 Feb;141(2 Suppl):S15-21. Review.

PMID:
11174354
12.
13.

[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Ravens U, Wettwer E, Schotten U, Wessel R, Dobrev D.

Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):64-72. Review. German.

PMID:
16786464
14.

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.

Savelieva I, Camm J.

Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):30-41. Review.

PMID:
18094671
15.

Mechanisms of atrial fibrillation and action of drugs used in its management.

Grant AO.

Am J Cardiol. 1998 Oct 16;82(8A):43N-49N. Review.

PMID:
9809900
16.

Dronedarone for the treatment of atrial fibrillation and atrial flutter.

Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.

Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08. Review.

17.

Dronedarone: an emerging agent with rhythm- and rate-controlling effects.

Wegener FT, Ehrlich JR, Hohnloser SH.

J Cardiovasc Electrophysiol. 2006 Sep;17 Suppl 2:S17-20. Review.

PMID:
16939434
18.

New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

Nattel S, Khairy P, Roy D, Thibault B, Guerra P, Talajic M, Dubuc M.

Drugs. 2002;62(16):2377-97. Review.

PMID:
12396229
19.

Theoretical possibilities for the development of novel antiarrhythmic drugs.

Varró A, Biliczki P, Iost N, Virág L, Hála O, Kovács P, Mátyus P, Papp JG.

Curr Med Chem. 2004 Jan;11(1):1-11. Review.

PMID:
14754422
20.

Class I or class III agents for atrial fibrillation: are asking the right question?

Pacifico A, Henry PD.

Pacing Clin Electrophysiol. 2003 Jul;26(7 Pt 2):1613-9. Review.

PMID:
12914611

Supplemental Content

Support Center